Scinex Corp (2376) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Scinex Corp (2376:JPX), powered by AI.

Current Price
¥660
P/E Ratio
13.5
Market Cap
3.7B
Sector
Communication Services
What is the Scinex Corp stock price forecast?

Scinex Corp is currently trading at ¥660. View real-time AI analysis on Alpha Lenz.

What is Scinex Corp insider trading activity?

View the latest insider trading data for Scinex Corp on Alpha Lenz.

What is Scinex Corp's P/E ratio?

Scinex Corp's P/E ratio is 13.5.

Scinex Corp

JPX · 2376
¥660+15(+2.33%)Market closedJPX regular session 09:00–15:00 JST
Ask about Scinex Corp's future dividend policy...
Alpha Chat Insight

Scinex Corp trades at a P/E of 13.5 (undervalued) with modest ROE of 3.5%.

Ask for details

Company Overview

Scinex Corp is a leading company specializing in the development and production of advanced biopharmaceutical solutions. The company's primary focus is on creating innovative therapeutic products aimed at addressing unmet medical needs, particularly in oncology and immunotherapy. By leveraging cutting-edge research and a strong commitment to scientific excellence, Scinex Corp has positioned itself at the forefront of the pharmaceutical and healthcare industries. One of the notable features of Scinex Corp is its robust pipeline of products in various stages of clinical development, which has captured the interest of both the medical community and investors. The company plays a crucial role in the healthcare market by providing novel treatments that can improve patient outcomes and contribute to the broader field of medical research. Scinex Corp's collaborations with academic institutions and pharmaceutical companies further enhance its capacity to bring new therapies to market efficiently. Headquartered in a major biotech hub, Scinex Corp continues to expand its influence through strategic partnerships and a strong commitment to advancing healthcare solutions, making it a key player in the pharmaceutical and biopharmaceutical sectors.

SectorCommunication Services
IndustryPublishing
Employees767

Company Statistics

FY 2025

Profile

¥3,701,268,780Market Cap
¥16,491,468,000Revenue
0.00Shares Out
767Employees

Margins

37.99%Gross
4.88%EBITDA
2.90%Operating
3.03%Pre-Tax
1.67%Net

Valuation

13.46P/E
0.46P/B
0.22EV/Sales
2.75EV/EBITDA
19.45P/FCF

Growth (CAGR)

5.18%Rev 3Yr
3.51%Rev 5Yr
1.73%Op Inc 3Yr
-3.88%Op Inc 5Yr
-0.44%Net Inc 3Yr
-5.67%Net Inc 5Yr

Returns

1.85%ROA
3.46%ROE
3.45%ROIC

Financial Health

¥4,657,472,000Cash & Cash Equivalents
¥2,108,975,000Net Debt
84.11%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Scinex Corp (ticker: 2376) is a company listed on JPX in the Communication Services sector (Publishing). It has approximately 767 employees. Market cap is $3.7B.

The current price is 660 with a P/E ratio of 13.46x and P/B of 0.46x.

ROE is 3.46% and operating margin is 2.90%. Annual revenue is $16.5B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Scinex Corp (Communication Services) Stock Forecast & Analysis ¥660 | Alpha Lenz